Skip to content

Identification of PtdIns(3,4)P2 effectors in human platelets using quantitative proteomics

Research output: Contribution to journalArticle

Original languageEnglish
Article number158575
Number of pages12
JournalBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Volume1865
Issue number2
Early online date16 Nov 2019
DOIs
DateAccepted/In press - 29 Oct 2019
DateE-pub ahead of print - 16 Nov 2019
DatePublished (current) - 1 Feb 2020

Abstract

After decades in PtdIns(3,4,5)P3's shadow, PtdIns(3,4)P2 has now emerged as a bona fide regulator of important cellular events, including endocytosis and cell migration. New understanding of PtdIns(3,4)P2's cellular roles has been possible via novel approaches to observe and quantify cellular PtdIns(3,4)P2 dynamics, alongside methods to target the kinases and phosphatases governing phosphoinositide turnover. Despite this, the mechanisms by which PtdIns(3,4)P2 orchestrates its cellular roles remain more poorly understood, most notably because, to date, few PtdIns(3,4)P2 effectors have been identified. Here, we develop and apply an affinity-proteomics strategy to conduct a global screen for PtdIns(3,4)P2 interactors in human platelets; a primary cell type with striking PtdIns(3,4)P2 accumulation. Through an integrated approach, coupling affinity capture of PtdIns(3,4)P2-binding proteins to both label-free and isobaric tag-based quantitative proteomics, we identify a diverse PtdIns(3,4)P2 interactome. Included are long-established PtdIns(3,4)P2-binding proteins such as PLEKHA1, PLEKHA2, AKT and DAPP1, and a host of potentially novel effectors, including MTMR5, PNKD, RASA3 and GAB3. The PtdIns(3,4)P2 interactome shows an enrichment of pleckstrin homology (PH) domain-containing proteins, and through bioinformatics and array analyses we characterise the PH domain of MTMR5 and define its phosphoinositide selectivity. The interactome is also diverse in function, including several proteins known to support protein trafficking and cytoskeletal mobilisation. Such proteins have the ability to drive key platelet events, and to fulfil recently-defined roles for PtdIns(3,4)P2 in a wider range of cell types. Moreover, this study will serve as a valuable resource for the future characterisation of effector-driven PtdIns(3,4)P2 function.

    Research areas

  • Phosphatidylinositol 3,4-bisphosphate, Phosphoinositide 3-kinase, Phosphoinositides, PIP2, Platelets, PtdIns(3,4)P

Download statistics

No data available

Documents

Documents

  • Full-text PDF (submitted manuscript)

    Rights statement: This is the submitted manuscript (SM). The accepted author manuscript version (AAM) will be made available online via Elsevier. Please refer to any applicable terms of use of the publisher.

    Submitted manuscript, 8.4 MB, PDF document

    Licence: CC BY-NC-ND

DOI

View research connections

Related faculties, schools or groups